# Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074

> **NCT02957617** · PHASE2 · TERMINATED · sponsor: **Biogen** · enrollment: 302 (actual)

## Conditions studied

- Neuropathic Pain From Lumbosacral Radiculopathy

## Interventions

- **DRUG:** BIIB074

## Key facts

- **NCT ID:** NCT02957617
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-10
- **Primary completion:** 2019-02-07
- **Final completion:** 2019-02-07
- **Target enrollment:** 302 (ACTUAL)
- **Why stopped:** The parent study did not meet its primary or secondary efficacy endpoints and therefore Sponsor decision to discontinue development in this indication.
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02957617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02957617, "Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02957617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*